EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS

The present group of inventions relates to novel compounds having formula (I), and to the salts, solvates or stereoisomers thereof, as well as to a pharmaceutical composition, a method of inhibiting the biological activity of epidermal growth factor receptor (EGFR), a method of treating diseases or...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MELCHAEVA, OLGA ANATOLEVNA, SOLDATOVA, IAROSLAVNA ALEXANDROVNA, SMETANIN, ILIA ALEXEEVICH, MINDICH, ALEKSEI LEONIDOVICH, MELESHINA, MARINA VIKTOROVNA, MAKSIMENKO, ELENA ALEKSANDROVNA, IAKOBSON, GEORGII VIKTOROVICH, KASATKINA, MARIIA ANDREEVNA, GORBUNOVA, SVETLANA LEONIDOVNA, POPKOVA, ALEKSANDRA VLADIMIROVNA, MOROZOV, DMITRY VALENTINOVICH, BEKETOVA, DARIA DMITRIEVNA, SILONOV, SERGEY ALEKSANDROVICH, KULISH, KIRILL IGOREVICH, ZAVIALOV, KIRILL VADIMOVICH, SHEKHAUTSOU, ARTSIOM EVGENIEVICH, KOZHEMYAKINA, NATALIA VLADIMIROVNA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present group of inventions relates to novel compounds having formula (I), and to the salts, solvates or stereoisomers thereof, as well as to a pharmaceutical composition, a method of inhibiting the biological activity of epidermal growth factor receptor (EGFR), a method of treating diseases or disorders mediated by EGFR activity, and the use of the claimed compounds or the aforementioned composition for treating a disease or a disorder mediated by EGFR activity. Le groupe d'inventions concerne de nouvelles compositions de la formule (I), leurs sels, solvates ou stéréoisomères ainsi qu'une composition pharmaceutique, un procédé d'inhibition de l'activité biologique du récepteur de facteur de croissance épidermique (EFGR), une méthode de traitement de maladies ou de perturbations à médiation par l'activité d'EFGR et d'utilisation de ces compositions ou de la composition en question pour traiter des troubles ou des perturbations à médiation par l'activité EFGR.